Ignite Creation Date:
2025-12-24 @ 3:53 PM
Ignite Modification Date:
2026-01-04 @ 2:54 AM
Study NCT ID:
NCT02178592
Status:
COMPLETED
Last Update Posted:
2021-01-12
First Post:
2014-06-26
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Open-label Study of Dolutegravir (DTG) or Efavirenz (EFV) for Human Immunodeficiency Virus (HIV) - Tuberculosis (TB) Co-infection
Sponsor:
ViiV Healthcare
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-01-23
Start Date Type:
ACTUAL
Primary Completion Date:
2017-11-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-03-06
Completion Date Type:
ACTUAL
First Submit Date:
2014-06-26
First Submit QC Date:
None
Study First Post Date:
2014-07-01
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2018-10-05
Results First Submit QC Date:
None
Results First Post Date:
2019-02-21
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-12-18
Last Update Post Date:
2021-01-12
Last Update Post Date Type:
ACTUAL